CSL Stock

CSL Shares Outstanding

The The number of shares of CSL (CSL.AX) as of Sep 9, 2026 is 486.22 M. In the previous year, The number of shares was 486.22 M — a change of 0.00% (lower).

Shares Outstanding

486.22 M

YoY

0.00%

Last updated:

In 2026, CSL had 486.22 M outstanding stocks, a 0.00% change from the 486.22 M stocks in the previous year.

The CSL Shares Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Shares Outstanding
Date
Shares Outstanding
Jan 1, 2024
486.22 M USD
Jan 1, 2025
486.22 M USD
Jan 1, 2026 (e)
486.22 USD
Jan 1, 2027 (e)
486.22 USD
Jan 1, 2028 (e)
486.22 USD
Jan 1, 2029 (e)
486.22 USD
Jan 1, 2030 (e)
486.22 USD
Jan 1, 2031 (e)
486.22 USD
The CSL Shares Outstanding history
YEARShares OutstandingYoY
est486.220.00%
est486.220.00%
est486.220.00%
est486.220.00%
est486.220.00%
est486.22-100.00%
486.22 M0.00%
486.22 M0.00%
486.22 M0.00%
486.22 M0.00%
486.22 M0.00%
486.22 M0.00%
486.22 M0.00%
486.22 M0.00%
486.22 M0.00%
486.22 M0.00%
486.22 M0.00%
486.22 M+97.19 M%
500.30-3.84%
520.30-3.97%
541.80-4.71%
568.60-4.87%
597.70+8.02%
553.30+0.34%
551.40-3.48%
571.30
Access this data via the Eulerpool API

CSL Number of shares

CSL shares outstanding

The number of shares of CSL was 486.22 M in 2025. This indicates how many shares CSL is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2024
485.20 M Stocks
Jan 1, 2025
486.22 M Stocks
Jan 1, 2026 (e)
486.22 M Stocks
Jan 1, 2027 (e)
486.22 M Stocks
Jan 1, 2028 (e)
486.22 M Stocks
Jan 1, 2029 (e)
486.22 M Stocks
Jan 1, 2030 (e)
486.22 M Stocks
Jan 1, 2031 (e)
486.22 M Stocks

CSL Stock analysis

What does CSL do? CSL Ltd is a global leading company in the field of biological medicine, manufacturing a wide range of products used in the therapy of diseases. The company is based in Melbourne, Australia, and is one of the largest biotech companies in the country. CSL was founded in 1916 by Australian researcher Frank Macfarlane Burnet. Originally named Commonwealth Serum Laboratories, the company focused on the research and production of vaccines. CSL was then privatized in 1994 and changed its name to CSL Ltd. CSL's business model is based on the production of protein products and plasma derivatives used in immunotherapy, hematology, and transplantation medicine. The company specializes in the production and marketing of products in three main areas: plasma products, vaccines, and animal health. CSL's plasma division includes a variety of products, including intravenous immunoglobulins (IVIG), platelets, and alpha-1 antitrypsin. The company operates a number of plasma centers in the US and Europe to collect raw materials for these products. In the vaccine sector, CSL is primarily involved in the manufacture of influenza vaccines and also offers a range of other vaccines, including vaccines against snake bites and encephalitis. In the field of animal health, CSL produces animal vaccines to prevent viral infections in livestock such as pigs, poultry, and cattle. CSL is committed to research and development to develop new products and improve existing ones. The company has a long history in the research and development of vaccines and immunotherapies and has established a strong presence in this field. The company employs over 27,000 people in 35 countries worldwide and operates production facilities in Australia, the US, Europe, and Asia. CSL's headquarters are located in Parkville, a suburb of Melbourne, Australia. CSL has an impressive track record in terms of growth and profitability and is a stable market leader in its field. The company has achieved solid growth rates in recent years and generated a revenue of $8.5 billion in 2019. CSL is a key player in the global healthcare industry and has established a reputation as a reliable supplier of medical products and services. The company is committed to developing innovative solutions to advance medical progress and make a positive contribution to human health. CSL is one of the most popular companies on Eulerpool.

Shares Outstanding Details

Evaluating CSL's Shares Outstanding

CSL's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in CSL’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding CSL’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in CSL’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about CSL stock

The number of shares of CSL is 486.22 M in 2026.

The number of shares of CSL changed from 486.22 M to 486.22 M, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The number of shares CSL since 2006 – with annual values, charts, and detailed analysis.

The number of shares indicates the total number of a company's shares. This includes not only the shares available on the market, but also the shares held by shareholders and the shares retained by the company.

Access this data via the Eulerpool API

Other — CSL

All Key Metrics — CSL